InvestorsHub Logo
Followers 17
Posts 752
Boards Moderated 0
Alias Born 10/20/2013

Re: None

Monday, 03/14/2016 10:12:57 PM

Monday, March 14, 2016 10:12:57 PM

Post# of 733
A memorable and pivotal night in the company's history.

A capital raise carried out without a discount at 3.30 AUD.

http://www.asx.com.au/asxpdf/20160315/pdf/435v33fzf94sv4.pdf

Lagoda Investment Management bought the new shares and now almost owns 10 % of the company. It seems they can't get enough. Very encouraging and significant.

http://www.asx.com.au/asxpdf/20160315/pdf/435v52hvvsmffr.pdf

And a roll out of the implant is now a fact.

http://www.asx.com.au/asxpdf/20160315/pdf/435v52hvvsmffr.pdf

With price negotiations pending we still have some uncertainty but it is nothing compared to what longs have endured over the past years.

Clinuvel is grossly undervalued. EPP alone will propel the pps to a much higher level. Label extensions, Vitiligo, pediatric EPP and the cream will do unimaginable things the the pps.

And most importantly: 1000 of patients with a broad variety of horrible disorders are about to benefit from this wonder drug that has such a huge future.

GLTA